Doha: Qatar’s Ministry of Public Health (MoPH) has issued a new circular regarding the importation of pharmaceutical products. Effective immediately, all imported medicines must have at least two-thirds of their shelf life remaining upon entry into the country.

The directive, released by the Department of Pharmacy and Drug Control, is designed to enhance quality standards and ensure the safety of medicines available in Qatar. Licensed pharmaceutical agents and importers are required to comply with these regulations unless they obtain an official exemption through the department’s approved Exemptions Guide.

Failure to adhere to these guidelines may result in various regulatory actions, including the suspension or revocation of exemption approvals, enhanced audits, or other corrective measures in accordance with national laws. This new mandate overrides any previous instructions regarding the remaining shelf life for medicinal imports.

Join the Rehaab Online WhatsApp group for timely updates  (Click here to join the group)